Journal News

How spider venom
could help relieve pain

Modified tarantula toxins can become effective pain treatments.
Courtney Chandler
March 20, 2020

Pain is a public health problem that often is not adequately addressed by current therapies. About 100 million adults in the United States suffer from chronic pain, and those who don’t will experience pain at some point in their lives, whether it be a scraped knee or surgery.

Spiders_Haplopelma-400x533.jpg
Syrio/Wikimedia Commons
This photo was taken at the “Spiders” exhibition at the Museo di storia
naturale Giacomo Doria in 2016.

There is a need for pain treatments that are safe, effective and not addictive. This is partially due to increased awareness of the highly addictive nature of many available pain medications. A recent article in the Journal of Biological Chemistry aims to meet these treatment needs using an unlikely source — spider venom.

Spider venoms are complex mixtures with a wide array of biologically active compounds that have one function: to subdue the spiders’ prey. Lead author Robert Neff and the Janssen Research and Development Neuroscience Drug Discovery Team focused on a peptide molecule called huwentoxin-IV found in the venom of a tarantula species called the Chinese bird spider.

This toxin is known to block a specific protein involved in pain signaling called Nav1.7. This protein is a sodium channel that amplifies pain signals to ensure they reach the brain. Neff said the researchers targeted Nav1.7 because previous research has shown that people who don’t have functioning Nav1.7 can’t feel pain despite being otherwise normal.

“Unfortunately, Nav1.7 is not an easy target,” Neff said. “Many other groups have tried to identify small molecules that block its activity, and to date none of these efforts have resulted in a marketed drug.”

As an added challenge, huwentoxin-IV is known to block other proteins in the sodium channel family that are important for normal nervous system function. Yet Neff and his team were not discouraged. They worked systematically to make small changes to huwentoxin-IV that would optimize its interaction with Nav1.7 and decrease its ability to block other sodium channel family members.

When they identified changes that had favorable effects, they combined them to make a molecule more effective at blocking pain signaling without disrupting the rest of the nervous system. However, combining single changes together did not always yield a molecule more effective than the single changes themselves, which was surprising, Neff said.

“This was a good reminder that small changes can have wide-ranging and unpredictable repercussions throughout the molecule.”

Although the work is still in preliminary stages, there is reason to believe we could see spider-derived pain treatments down the line. A tarantula toxin previously identified by the group in a parallel study in 2017 has been tested in preclinical studies. While their current designer molecules are not yet in preclinical trials, Neff and his team have produced a large library of subtly different toxins and cataloged their activities in their more recent study, which should be useful for the pain research community at large.

“We hope that other interested investigators will be able to use these datasets to further their research,” Neff said. “We want to help accelerate the discovery of a new, safe, and nonaddictive pain medication.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a careers columnist for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Is location everything?
Journal News

Is location everything?

Aug. 9, 2022

A lab at the University of Illinois Chicago develops site-specific tools to probe the cellular function of cholesterol.

Did gonorrhea give us grandparents?
News

Did gonorrhea give us grandparents?

Aug. 9, 2022

UC San Diego researchers track evolution of gene variant that supports cognitive health in older humans but may have first emerged to protect against bacteria.

Why researchers are studying menstrual blood
News

Why researchers are studying menstrual blood

Aug. 7, 2022

Some scientists are challenging the conventional view that menstrual effluent is merely a waste product.

From the journals: JBC
Journal News

From the journals: JBC

Aug. 5, 2022

Defining functional redundancy in mycobacteria. Finding aqueous pores in sodium channels. Identifying new substrates for a ubiquitin ligase. Read about papers on these topics.

Cannabis hyperemesis and the cure that burns
Feature

Cannabis hyperemesis and the cure that burns

Aug. 3, 2022

When chronic users of marijuana show up in the ER with uncontrollable vomiting, physicians have a salve that can relieve their pain. Scientists aren’t sure why it works.

‘Filling the void of the virosphere’
Feature

‘Filling the void of the virosphere’

July 31, 2022

Discovery of thousands of oceanic RNA virus species yields new insights into their roles in nature, including carbon capture.